A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
about
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screenAdvances in Zika Virus Research: Stem Cell Models, Challenges, and OpportunitiesZika virus cell tropism in the developing human brain and inhibition by azithromycinPurification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsZika virus: from pathogenesis to disease controlChloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell ModelsDengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arbovirusesThe clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationScreening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika VirusDouble paradigm shift for the antibiotics’ activity on viruses: Zika’s lessonEvaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse ModelUsing brain organoids to understand Zika virus-induced microcephalyThe Race To Find Antivirals for Zika Virus.Zika infection and the development of neurological defectsPotential mechanisms of Zika-linked microcephalyBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondManagement of Viral Central Nervous System Infections: A Primer for CliniciansPediatric Drug Nitazoxanide: A Potential Choice for Control of Zika.Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionZika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.DNA vaccination protects mice against Zika virus-induced damage to the testesZika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.Current Status of Dengue Therapeutics Research and Development.Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library.Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae.Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future PerspectivesScreening of FDA-Approved Drugs for Inhibitors against Japanese Encephalitis Virus Infection.Zika Virus Research Models.Antivirals for allosteric inhibition of Zika virus using a homology model and experimentally determined structure of envelope protein.A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Müller cells following Zika virus infection.High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain.Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice.Structural basis of Zika virus methyltransferase inhibition by sinefungin.Antiviral activity of cationic amphiphilic drugs.Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?Zika virus infection damages the testes in mice.
P2860
Q26747306-F9DC4813-1B45-4BB7-B99D-E03E20C586CDQ27980653-D1724B0F-0812-4526-AEE2-B6297E9244E3Q28119685-B90557EE-AA09-4A82-B28D-CB6DE29352B1Q28223065-80142BF9-88AE-4C0D-AAC6-9A6F23533318Q28278045-5F0D0F78-BC37-412F-A3AC-D748193C1F92Q28353981-C02559E8-97AE-4EB2-A95A-D9C78952CF85Q28577861-C58F50DE-DDC5-49AD-A087-5407585F1495Q28595139-15A2F1AC-9EC3-4ACF-912F-ADD298F1BF81Q28595153-3D86513C-B089-4A7C-8219-DCA042668A9FQ28656388-805192DC-E09D-46A6-A363-47D3AF38355AQ28804198-AE679D93-914E-49AE-91EF-B711AC449DC9Q28950498-2697F28C-DBCA-41EB-80F6-127CF07447EEQ28973572-1A51BC31-95BD-4E93-A9F5-C407B2A2C87AQ29051492-21DD1F74-8E78-4EBE-8508-539BC7581435Q29168664-D7D945F4-7CFD-49EC-8977-CBBAD44EE11CQ29364523-C02922C5-ED88-48E1-A8FE-82B21D8495AAQ29994527-35A183CC-359D-4A20-8933-D67FF8F4B03BQ30145523-39D66376-40FC-41E9-9D8F-C2DB353ECB31Q30145642-0D2E6ABD-9E06-4CDA-880C-206B40A2B3ABQ30145664-CC8DA8C2-87A9-4A8A-B0EA-450D67E7692CQ30145688-68CCDA53-809E-40EC-9861-79403F8AF812Q30402859-69096C32-0AEF-4E58-A807-A7791BAAF8BCQ30855414-63A28BE8-E84E-475F-856C-1A5AD5F4E77CQ32183208-0EF9495E-6062-4984-8D9B-6BCF9361612AQ33552896-62B53DF7-AE38-4FD6-B4FF-F545B250E568Q33715238-F94582EF-B0CB-4F37-AB6E-B127A6B17347Q36210865-DB526F7C-6549-4752-8B5B-B10DA5D6D4C2Q38156553-AEA32CCE-01F4-4EC9-8059-2BC26742F0D3Q38156667-B30A9AAD-9E13-4FE6-8739-8A04C0D27A9FQ38156719-DB732DC0-3B37-4EBD-AD69-8BBEDE5593A2Q38156734-E796C65F-1C05-4409-B069-771A321DBD81Q38157277-BBF605FB-0D39-46E3-88A3-2CF8821E7ADCQ38157419-FFDE1EA0-AEB8-4139-8F66-043F61B6B7CEQ38157447-72A05499-2118-4854-B1C7-462965D75908Q38157498-5758D30B-43C8-4B85-B0C7-18E960FD7AE9Q38158000-1178E9D8-EF1B-41D9-AE03-7A3091490484Q38867867-4C34400B-3A56-478E-AD68-B4777A100E54Q39175768-DC9BCF12-A7EE-4F49-A4AF-D917DBDE2A9AQ40037723-C4D40CC7-D43F-4401-9E1D-96AD7A76C592Q40053231-E357F1AC-7162-4970-92F5-A8DF209F2C18
P2860
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@ast
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@en
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@nl
type
label
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@ast
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@en
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@nl
prefLabel
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@ast
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@en
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@nl
P2093
P2860
P50
P3181
P1433
P1476
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
@en
P2093
Erica L. McGrath
Gaddiel Galarza-Muñoz
Geraldine Schott-Lerner
Junling Gao
K. Reddisiva Prasanth
Mariano A. Garcia-Blanco
Nicholas J. Barrows
Rafael K. Campos
Ramkumar Menon
P2860
P304
P3181
P356
10.1016/J.CHOM.2016.07.004
P407
P577
2016-07-01T00:00:00Z